Keynote Speech Featuring Dr. Phillip A. Sharp and Panel Discussion
Innovation through Biotechnology: Convergence with Engineering and AI in Public Health
Presented by research@BSPH, join the discussion at the launch of the newly formed Innovation Translation Council. Led by council Chair Anthony Leung, professor, Biochemistry and Molecular Biology, the Council will propel and organize the School’s efforts to increase the commercialization of research outcomes into products and services that will save lives, millions at a time.
This launch will feature a keynote speech from Dr. Phillip A. Sharp, whose 1977 discovery of RNA splicing set the foundation for today’s biomedical industry. He will also speak on his experience founding Biogen, a global biotechnology company that focuses on developing treatments and medicines for neurological and chronic diseases. Following Dr. Sharp’s keynote speech, a panel of leaders in the biotechnology industry will lead the audience through their experience in the sector.
Event Details:
May 19 | 3:30 p.m. – 6:30 p.m. ET
Sheldon Hall W1214
615 N. Wolfe Street
Baltimore, Maryland 21205
After the keynote and panel, join the Council in the Gallery for hors d’oeuvres, discussion, and networking. All BSPH faculty, students, and staff are welcome to join this event.
Dr. Phillip Sharp’s research interests have centered on the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing. His work in 1977 provided the first indications of “discontinuous genes” in mammalian cells. This discovery fundamentally changed scientists’ understanding of gene structure and earned him the 1993 Nobel Prize in Physiology or Medicine. A native of Kentucky, Dr. Sharp earned a B.A. degree from Union College, Barbourville, KY, and a Ph.D. in chemistry from the University of Illinois, Champaign-Urbana. Dr. Sharp was a co-founder of Biogen (1978) and served as chair of its Scientific Advisory Board and member of the Board of Directors. He co-founded Alnylam Pharmaceuticals (2002) and serves as chair of its Scientific Advisory Board and member of the Board of Directors.